The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Deciphering the nuclear bile acid receptor FXR paradigm
Open accessAbstract
Originally called retinoid X receptor interacting protein 14 (RIP14), the farnesoid X receptor (FXR) was renamed after the ability of its rat form to bind supra-physiological concentrations of farnesol. In 1999 FXR was de-orphanized since primary bile acids were identified as natural ligands. Strongly expressed in the liver and intestine, FXR has been shown to be the master transcriptional regulator of several entero-hepatic metabolic pathways with relevance to the pathophysiology of conditions such as cholestasis, fatty liver disease, cholesterol gallstone disease, intestinal inflammation and tumors. Furthermore, given the importance of FXR in the gut-liver axis feedbacks regulating lipid and glucose homeostasis, FXR modulation appears to have great input in diseases such as metabolic syndrome and diabetes. Exciting results from several cellular and animal models have provided the impetus to develop synthetic FXR ligands as novel pharmacological agents. Fourteen years from its discovery, FXR has gone from bench to bedside; a novel nuclear receptor ligand is going into clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,355
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J.-M. A., Hammer, R. E., & Mangelsdorf, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81432-4 · Cited by 1,436
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421025 · Cited by 1,397
Self-citationMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233
Peroxisome proliferator-activated receptor a target genes
Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3216-3 · Cited by 1,218
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 4×
“Moreover, it has been recently shown that part of the antibacterial activity of BAs is mediated by FXR [Inagaki et al., 2006].”
InfluentialSelf-citationDisordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,008
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Farnesoid X receptor is essential for normal glucose homeostasis
Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 882
Colorectal Cancer: Molecules and Populations
Potter, J. D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.916 · Cited by 881
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., & Mukaida, N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32453 · Cited by 832
Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 793
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
Paumgartner, G., & Beuers, U. (2002) · Hepatology · doi:10.1053/jhep.2002.36088 · Cited by 748
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
Bull, L. N., van Eijk, M. J. T., Pawlikowska, L., DeYoung, J. A., Juijn, J. A., Liao, M., Klomp, L. W. J., Lomri, N., Berger, R., Scharschmidt, B. R., et al. (1998) · Nature Genetics · doi:10.1038/ng0398-219 · Cited by 736
Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J.-F., Desrochers, M., Burdelski, M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 735
Nakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10663 · Cited by 680
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645
Portincasa, P., Moschetta, A., & Palasciano, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69044-2 · Cited by 643
Self-citationMolecular Diagnosis of Familial Adenomatous Polyposis
Powell, S. M., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292702 · Cited by 599
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576
The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.-C., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 552
A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
ADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose
Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., le Lièpvre, X., Berthelier-Lubrano, C., Spiegelman, B., Kim, J. B., Ferré, P., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3760 · Cited by 548
Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
Maloney, P. R., Parks, D. J., Haffner, C. D., Fivush, A. M., Chandra, G., Plunket, K. D., Creech, K. L., Moore, L. B., Wilson, J. G., Lewis, M. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002127 · Cited by 527
Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488
Pineda Torra, I., Claudel, T., Duval, C., Kosykh, V., Fruchart, J.-C., & Staels, B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0120 · Cited by 487
Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
Chiang, J. Y. L. (2002) · Endocrine Reviews · doi:10.1210/er.2000-0035 · Cited by 484
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C. S., Salen, G., Shefer, S., BATTA, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15387 · Cited by 468
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C., Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 457
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
Seol, W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.72 · Cited by 393
The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis
Lambert, G., Amar, M. J. A., Guo, G., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 392
A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
Oelkers, P., Kirby, L. C., Heubi, J. E., & Dawson, P. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119355 · Cited by 385
Dawson, P. A., Hubbert, M., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., & Ballatori, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412752200 · Cited by 381
Intrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome
Rioseco, A. J., Ivankovic, M. B., Manzur, A., Hamed, F., Kato, S. R., Parer, J. T., & Germain, A. M. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70304-3 · Cited by 380
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 368
Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 364
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J. M., & Gonzalez, F. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl249 · Cited by 357
Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene
Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T., & Besnard, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29749 · Cited by 353
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 349
Methylation at arginine 17 of histone H3 is linked to gene activation
Bauer, U., Daujat, S., Nielsen, S. J., Nightingale, K., & Kouzarides, T. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf013 · Cited by 342
Dawson, P. A., Haywood, J., Craddock, A. L., Wilson, M., Tietjen, M., Kluckman, K., Maeda, N., & Parks, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306370200 · Cited by 337
Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P. A., Soroka, C. J., Boyer, J. L., Madejczyk, M. S., & Li, N. (2005) · Hepatology · doi:10.1002/hep.20961 · Cited by 335
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 325
Self-citationGoulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315
Craddock, A. L., Love, M. W., Daniel, R. W., Kirby, L. C., Walters, H. C., Wong, M. H., & Dawson, P. A. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.1.g157 · Cited by 310
Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR
Mi, L.-Z., Devarakonda, S., Harp, J. M., Han, Q., Pellicciari, R., Willson, T. M., Khorasanizadeh, S., & Rastinejad, F. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00112-6 · Cited by 307
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Stayrook, K. R., Bramlett, K. S., Savkur, R. S., Ficorilli, J., Cook, T., Christe, M. E., Michael, L. F., & Burris, T. P. (2005) · Endocrinology · doi:10.1210/en.2004-0965 · Cited by 288
Carter, B. A., Taylor, O. A., Prendergast, D. R., Zimmerman, T. L., Von Furstenberg, R., Moore, D. D., & Karpen, S. J. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3181256492 · Cited by 286
Zhang, Y., Kast-Woelbern, H. R., & Edwards, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209505200 · Cited by 286
Oguma, K., Oshima, H., Aoki, M., Uchio, R., Naka, K., Nakamura, S., Hirao, A., Saya, H., Taketo, M. M., & Oshima, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.105 · Cited by 280
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
Claudel, T., Inoue, Y., Barbier, O., Duran-Sandoval, D., Kosykh, V., Fruchart, J., Fruchart, J.-C., Gonzalez, F. J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00896-5 · Cited by 268
Reddy, B. S., Hedges, A. R., Laakso, K., & Wynder, E. L. (1978) · Cancer · doi:10.1002/1097-0142(197812)42:6<2832::aid-cncr2820420644>3.0.co;2-l · Cited by 260
Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
Duran-Sandoval, D., Mautino, G., Martin, G., Percevault, F., Barbier, O., Fruchart, J.-C., Kuipers, F., & Staels, B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.890 · Cited by 257
van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Putative Metabolic Effects of the Liver X Receptor (LXR)
Steffensen, K. R., & Gustafsson, J.-A. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s36 · Cited by 250
Falany, C. N., Johnson, M. R., Barnes, S., & Diasio, R. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32178-6 · Cited by 248
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 247
Cui, J., Huang, L., Zhao, A., Lew, J.-L., Yu, J., Sahoo, S., Meinke, P. T., Royo, I., Peláez, F., & Wright, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209323200 · Cited by 246
Expression and activation of the farnesoid X receptor in the vasculature
Bishop-Bailey, D., Walsh, D. T., & Warner, T. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400046101 · Cited by 242
Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
Modica, S., Murzilli, S., Salvatore, L., Schmidt, D. R., & Moschetta, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1791 · Cited by 237
Self-citationBile acid-induced negative feedback regulation of the human ileal bile acid transporter
Neimark, E., Chen, F., Li, X., & Shneider, B. L. (2004) · Hepatology · doi:10.1002/hep.20295 · Cited by 234
G UGULIPID: A Natural Cholesterol-Lowering Agent
Urizar, N. L., & Moore, D. D. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073102 · Cited by 233
Rao, A., Haywood, J., Craddock, A. L., Belinsky, M. G., Kruh, G. D., & Dawson, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712328105 · Cited by 225
Diet and cancer: one view at the start of the millennium.
Willett, W. C. (2001) · PubMed · Cited by 220
Maran, R. R. M., Thomas, A., Roth, M., Sheng, Z., Esterly, N., Pinson, D., Gao, X., Zhang, Y., Ganapathy, V., Gonzalez, F. J., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145409 · Cited by 220
Enterohepatic Circulation of Bile Salts in Farnesoid X Receptor-deficient Mice
Kok, T., Hulzebos, C. V., Wolters, H., Havinga, R., Agellon, L. B., Stellaard, F., Shan, B., Schwarz, M., & Kuipers, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306309200 · Cited by 219
The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
Lew, J.-L., Zhao, A., Yu, J., Huang, L., de Pedro, N., Peláez, F., Wright, S. D., & Cui, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306422200 · Cited by 213
Landrier, J.-F., Eloranta, J. J., Vavricka, S. R., & Kullak-Ublick, G. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00430.2005 · Cited by 213
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters
Huber, R. M., Murphy, K., Miao, B., Link, J. R., Cunningham, M. R., Rupar, M. J., Gunyuzlu, P. L., Haws, T. F., Kassam, A., Powell, F., et al. (2002) · Gene · doi:10.1016/s0378-1119(02)00557-7 · Cited by 210
De Fabiani, E., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210
Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor
Song, C. S., Echchgadda, I., Baek, B.-S., Ahn, S. C., Oh, T., Roy, A. K., & Chatterjee, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107557200 · Cited by 208
Liver X Receptors as Insulin-mediating Factors in Fatty Acid and Cholesterol Biosynthesis
Tobin, K. A. R., Ulven, S. M., Schuster, G. U., Steineger, H. H., Andresen, S. M., Gustafsson, J.-Å., & Nebb, H. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109771200 · Cited by 207
Barbier, O., Torra, I. P., Sirvent, A., Claudel, T., Blanquart, C., Duran-Sandoval, D., Kuipers, F., Kosykh, V., Fruchart, J.-C., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00388-3 · Cited by 204
Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation
Pircher, P. C., Kitto, J. L., Petrowski, M. L., Tangirala, R. K., Bischoff, E. D., Schulman, I. G., & Westin, S. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302128200 · Cited by 198
Differential Regulation of Rat and Human CYP7A1 by the Nuclear Oxysterol Receptor Liver X Receptor-α
Goodwin, B., Watson, M. A., Kim, H., Miao, J., Kemper, J. K., & Kliewer, S. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0246 · Cited by 198
The Hypolipidemic Natural Product Guggulsterone Acts as an Antagonist of the Bile Acid Receptor
Wu, J. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1590 · Cited by 196
Pellicciari, R., Costantino, G., Camaioni, E., Sadeghpour, B. M., Entrena, A., Willson, T. M., Fiorucci, S., Clerici, C., & Gioiello, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049904b · Cited by 194
Yu, J., Lo, J.-L., Huang, L., Zhao, A., Metzger, E., Adams, A., Meinke, P. T., Wright, S. D., & Cui, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200474200 · Cited by 189
Hanniman, E. A., Lambert, G., McCarthy, T. C., & Sinal, C. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500390-jlr200 · Cited by 179
Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis
Mennone, A., Soroka, C. J., Cai, S.-Y., Harry, K., Adachi, M., Hagey, L., Schuetz, J. D., & Boyer, J. L. (2006) · Hepatology · doi:10.1002/hep.21158 · Cited by 179
FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
Lee, H., Zhang, Y., Lee, F. Y., Nelson, S. F., Gonzalez, F. J., & Edwards, P. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500417-jlr200 · Cited by 178
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
Otte, K., Kranz, H., Kober, I., Thompson, P., Hoefer, M., Haubold, B., Remmel, B., Voss, H., Kaiser, C., Albers, M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.864-872.2003 · Cited by 176
Bile???Acid???Sequestrants???and???the???Treatment of Type??2??Diabetes??Mellitus
Staels, B., & Kuipers, F. (2007) · Drugs · doi:10.2165/00003495-200767100-00001 · Cited by 176
Gnerre, C., Bl??ttler, S., Kaufmann, M. R., Looser, R., & Meyer, U. A. (2004) · Pharmacogenetics · doi:10.1097/00008571-200410000-00001 · Cited by 173
Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration
Li, Y. T. Y., Swales, K. E., Thomas, G. J., Warner, T. D., & Bishop-Bailey, D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152694 · Cited by 171
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
Stedman, C., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G., Evans, R. M., & Downes, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604772103 · Cited by 170
FXR Deficiency Causes Reduced Atherosclerosis in Ldlr−/−Mice
Zhang, Y., Wang, X., Vales, C., Lee, F. Y., Lee, H., Lusis, A. J., & Edwards, P. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235697.35431.05 · Cited by 169
Lee, J., Azzaroli, F., Wang, L., Soroka, C. J., Gigliozzi, A., Setchell, K. D. R., Kramer, W., & Boyer, J. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.29608 · Cited by 166
Nishigori, H., Tomura, H., Tonooka, N., Kanamori, M., Yamada, S., Sho, K., Inoue, I., Kikuchi, N., Onigata, K., Kojima, I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.575 · Cited by 165
A meta-analysis of cholecystectomy and risk of colorectal cancer
Giovannucci, E., Colditz, G. A., & Stampfer, M. J. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90018-8 · Cited by 164
Molecular pathogenesis of colorectal cancer: Implications for molecular diagnosis
Arnold, C. N., Goel, A., Blum, H. E., & Richard Boland, C. (2005) · Cancer · doi:10.1002/cncr.21462 · Cited by 162
Rizzo, G., Sante, M. D., Mencarelli, A., Renga, B., Gioiello, A., Pellicciari, R., & Fiorucci, S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023820 · Cited by 161
Intestinal cancer after cholecystectomy: Is bile involved in carcinogenesis?
Lagergren, J., Ye, W., & Ekbom, A. (2001) · Gastroenterology · doi:10.1053/gast.2001.27083 · Cited by 158
Swales, K. E., Korbonits, M., Carpenter, R., Walsh, D. T., Warner, T. D., & Bishop‐Bailey, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2399 · Cited by 157
Maglich, J. M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg444 · Cited by 156
Araya, Z., & Wikvall, K. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00031-1 · Cited by 156
Lee, Y.-K., Schmidt, D. R., Cummins, C. L., Choi, M., Peng, L., Zhang, Y., Goodwin, B. J., Hammer, R. E., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0565 · Cited by 154
Mataki, C., Magnier, B. C., Houten, S. M., Annicotte, J., Argmann, C., Thomas, C., Overmars, H., Kulik, W., METZGER, D., Auwerx, J. H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00852-07 · Cited by 148
Iron and hepatocellular carcinoma
Deugnier, Y., & Turlin, B. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02430.x · Cited by 147
Denk, G. U., Soroka, C. J., Takeyama, Y., Chen, W.-S., Schuetz, J. D., & Boyer, J. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.001 · Cited by 147
Downregulation of Endothelin-1 by Farnesoid X Receptor in Vascular Endothelial Cells
He, F., Li, J., Mu, Y., Kuruba, R., Ma, Z., Wilson, A. S., Alber, S. M., Jiang, Y., Stevens, T., Watkins, S. C., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000200400.55539.85 · Cited by 144
Ricketts, M., Boekschoten, M. V., Kreeft, A. J., Hooiveld, G. J. E. J., Moen, C. J. A., Müller, M. M., Frants, R. R., Kasanmoentalib, S., Post, S. M., Princen, H. M. G., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0133 · Cited by 143
Novel pathways of bile acid metabolism involving CYP3A4
Bodin, K., Lindbom, U., & Diczfalusy, U. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.003 · Cited by 141
Induction of gallstones in mice by feeding a cholesterol-cholic acid containing diet
Tepperman, J., Caldwell, F. T., & Tepperman, H. M. (1964) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1964.206.3.628 · Cited by 141
Glucocorticoid Signaling Is Perturbed by the Atypical Orphan Receptor and Corepressor SHP
Borgius, L., Steffensen, K. R., Gustafsson, J.-Α., & Treuter, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205641200 · Cited by 139
BULUK, K., Zuch, A., & Czokało, M. (1972) · PubMed · Cited by 137
Gong, Y., Everett, E. T., Schwartz, D. A., Norris, J. S., & Wilson, F. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4741 · Cited by 136
Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients
Savoia, C., Touyz, R. M., Volpe, M., & Schiffrin, E. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000253968.95136.b8 · Cited by 135
The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand
Burris, T. P., Montrose, C., Houck, K. A., Osborne, H. E., Bocchinfuso, W. P., Yaden, B. C., Cheng, C., Zink, R. W., Barr, R. J., Hepler, C. D., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007054 · Cited by 135
Effects of FXR in foam-cell formation and atherosclerosis development
Guo, G. L., Santamarina-Fojo, S., Akiyama, T. E., Amar, M. J., Paigen, B. J., Brewer, B., & Gonzalez, F. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.09.018 · Cited by 134
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Crouse, J. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90692-9 · Cited by 130
FXR-mediated regulation of eNOS expression in vascular endothelial cells
Jiang, L., Wilson, A. S., Kuruba, R., Zhang, Q., Gao, X., He, F., Zhang, L., Pitt, B. R., Xie, W., & Song, L. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm016 · Cited by 127
Nozawa, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.159 · Cited by 126
Beil, U., Crouse, J. R., Einarsson, K., & Grundy, S. M. (1982) · Metabolism · doi:10.1016/0026-0495(82)90231-1 · Cited by 124
Shibata, M., Morizane, T., Uchida, T., Yamagami, T., Onozuka, Y., Nakano, M., Mitamura, K., & Ueno, Y. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08002-1 · Cited by 121
Brobst, D., Ding, X., Creech, K. L., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064329 · Cited by 116
Marschall, H., Wagner, M., Bodin, K., Zollner, G., Fickert, P., Gumhold, J., Silbert, D., Fuchsbichler, A., Sjövall, J., & Trauner, M. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500427-jlr200 · Cited by 113
Twisk, J., Hoekman, M. F. M., Lehmann, E. M., Meijer, P., Mager, W. H., & Princen, H. M. G. (1995) · Hepatology · doi:10.1002/hep.1840210235 · Cited by 108
Identification of Gene-selective Modulators of the Bile Acid Receptor FXR
Dussault, I., Beard, R., Lin, M., Hollister, K., Chen, J., Xiao, J. H., Chandraratna, R., & FORMAN, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209863200 · Cited by 106
Angelin, B., Hershon, K. S., & Brunzell, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5434 · Cited by 105
Solaas, K., Ulvestad, A., Söreide, O., & Kase, B. F. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32022-8 · Cited by 102
Fang, H.-L., Strom, S. C., Cai, H., Falany, C. N., Kocarek, T. A., & Runge‐Morris, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005389 · Cited by 102
Rudel, L. L., Deckelman, C., Wilson, M., Scobey, M., & Anderson, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117255 · Cited by 101
Impaired pressor reactivity in cirrhosis: Evidence for a peripheral vascular defect
Macgilchrist, A. J., Sumner, D. J., & Reid, J. L. (1991) · Hepatology · doi:10.1002/hep.1840130413 · Cited by 99
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor
Savkur, R. S., Bramlett, K. S., Michael, L. F., & Burris, T. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.141 · Cited by 96
Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor
Anisfeld, A. M., Kast-Woelbern, H. R., Meyer, M. E., Jones, S. A., Zhang, Y., Williams, K. J., Willson, T. M., & Edwards, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302505200 · Cited by 96
Liver receptor homolog-1, an emerging metabolic modulator
Lee, Y. (2008) · Frontiers in bioscience · doi:10.2741/3128 · Cited by 94
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
Bilz, S., Samuel, V. T., Morino, K., Savage, D. B., Choi, C. S., & Shulman, G. I. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00355.2005 · Cited by 93
Serum Lipids in Cholelithiasis: Effect of Chenodeoxycholic Acid Therapy
Bell, G. D., Lewis, B., Petrie, A., & Dowling, R. H. (1973) · BMJ · doi:10.1136/bmj.3.5879.520 · Cited by 91
Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.
Bateson, M. C., Maclean, D., Evans, J., & Bouchier, I. A. D. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb01632.x · Cited by 90
Activation of the orphan receptor RIP14 by retinoids
Zavacki, A. M., Lehmann, J. M., Seol, W., Willson, T. M., Kliewer, S. A., & Moore, D. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7909 · Cited by 88
Serum Concentrations of Bile Acid Glucuronides in Hepatobiliary Diseases
Takikawa, H., Otsuka, H., Beppu, T., Seyama, Y., & Yamakawa, T. (2009) · Digestion · doi:10.1159/000198952 · Cited by 87
Transient impairment of the adaptive response to fasting in FXR‐deficient mice
Cariou, B., van Harmelen, K., Durán-Sandoval, D., van Dijk, T. H., Grefhorst, A., Bouchaert, E., Fruchart, J., Gonzalez, F. J., Kuipers, F., & Staels, B. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.033 · Cited by 87
Qin, P., Tang, X., Elloso, M. M., & Harnish, D. C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01182.2005 · Cited by 86
Kovacs, P. L., Kress, R., Rocha, J., Kurtz, U., Miquel, J. F., Nervi, F. O., Méndez‐Sánchez, N., Uribe, M., Bock, H. H., Schirin-Sokhan, R., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.027 · Cited by 84
Primary Sclerosing Cholangitis: Epidemiology, Natural History, and Prognosis
Levy, C., & Lindor, K. D. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933560 · Cited by 84
Katzenellenbogen, M., Pappo, O., Barash, H., Klopstock, N., Mizrahi, L., Olam, D., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., Mitchell, L. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2937 · Cited by 83
Rizzo, G., Renga, B., Antonelli, E., Passeri, D., Pellicciari, R., & Fiorucci, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012104 · Cited by 82
Christie, D. M., Dawson, P. A., Thevananther, S., & Shneider, B. L. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.2.g377 · Cited by 82
Jansen, P. L. M., Müller, M. M., & Sturm, E. (2001) · Hepatology · doi:10.1053/jhep.2001.29625 · Cited by 81
Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation
Fujino, T., Une, M., Imanaka, T., Inoue, K., & Nishimaki‐Mogami, T. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300215-jlr200 · Cited by 80
Ananthanarayanan, M., Li, S., Balasubramaniyan, N., Suchy, F. J., & Walsh, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410021200 · Cited by 78
Love, J. D., Gooch, J. T., Benkő, S., Li, C., Nagy, L., Chatterjee, K., Evans, R. M., & Schwabe, J. W. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110869200 · Cited by 76
New insights into bile acid transport
Love, M. W., & Dawson, P. A. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00007 · Cited by 76
Marzolini, C., Tirona, R. G., Gervasini, G., Balasubramanian, P., Assem, M., Lee, W., Leake, B. F., Schuetz, J. D., Schuetz, E. G., & Kim, R. B. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0025 · Cited by 73
Molavi, B., Chen, J., & Mehta, J. L. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2005 · Cited by 72
Waarde, W. M. B., Verkade, H. J., Wolters, H., Havinga, R., Baller, J., Bloks, V. W., Müller, M. M., Sauer, P. J. J., & Kuipers, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.33582 · Cited by 71
Scarabin, P., Arveiler, D., Amouyel, P., et al. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00309-x · Cited by 70
Nishimaki‐Mogami, T., Une, M., Fujino, T., Sato, Y., Tamehiro, N., Kawahara, Y., Shudo, K., & Inoue, K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400102-jlr200 · Cited by 69
Nilsson, L.-M., Abrahamsson, A., Sahlin, S., Gustafsson, U. O., Angelin, B., Parini, P., & Einarsson, C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.196 · Cited by 69
FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
Zhang, Q., He, F., Kuruba, R., Gao, X., Wilson, A. S., Li, J., Billiar, T. R., Pitt, B. R., Xie, W., & Li, S. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm068 · Cited by 68
Howard, W. R., Pospisil, J. A., Njolito, E., & Noonan, D. J. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8869 · Cited by 67
Modulation of rat hepatocyte proliferation by bile salts: In vitro and In vivo studies
Barone, M., Francavilla, A., Polimeno, L., Ierardi, E., Romanelli, D., Berloco, P., Leo, A. D., & Panella, C. (1996) · Hepatology · doi:10.1053/jhep.1996.v23.pm0008621149 · Cited by 64
Bile acid pool changes and regulation of cholate synthesis in experimental diabetes
Nervi, F. O., Severín, C., & Valdivieso, V. D. (1978) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(78)90064-4 · Cited by 64
Kallikreins and Kinins: Molecular Characteristics and Cellular and Tissue Responses
Margolius, H. S. (1996) · Diabetes · doi:10.2337/diab.45.1.s14 · Cited by 63
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio
Modica, S. (2009) · Frontiers in bioscience · doi:10.2741/3563 · Cited by 61
Self-citationGutierrez, A., Ratliff, E. P., Andres, A. M., Huang, X., McKeehan, W. L., & Davis, R. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000195793.73118.b4 · Cited by 60
Lu, Y. F., Heydel, J., Li, X., Bratton, S. M., Lindblom, T. H., & Radominska-p, A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003061 · Cited by 58
Ueno, Y., Moriyama, M., Uchida, T., & Arakawa, Y. (2001) · Hepatology · doi:10.1053/jhep.2001.21902 · Cited by 58
A Single Hydroxyl Group Governs Ligand Site Selectivity in Human Ileal Bile Acid Binding Protein
Tochtrop, G. P., DeKoster, G. T., Covey, D. F., & Cistola, D. P. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047589c · Cited by 57
Determinants of Cooperativity and Site Selectivity in Human Ileal Bile Acid Binding Protein
Tőke, O., Monsey, J. D., DeKoster, G. T., Tochtrop, G. P., Tang, C., & Cistola, D. P. (2005) · Biochemistry · doi:10.1021/bi051781p · Cited by 56
α1‐antitrypsin deficiency and liver disease
Birrer, P., McElvaney, N. G., Chang‐Stroman, L. M., & Crystal, R. G. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01797921 · Cited by 54
Savkur, R. S., Thomas, J. S., Bramlett, K. S., Gao, Y., Michael, L. F., & Burris, T. P. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072124 · Cited by 53
Pellicciari, R., Gioiello, A., Costantino, G., Sadeghpour, B. M., Rizzo, G., Meyer, U., Parks, D. J., Entrena-Guadix, A., & Fiorucci, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060294k · Cited by 51
Niesor, E. J., Flach, J., Antoni, I., Perez, A., & Bentzen, C. L. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398185 · Cited by 49
Ratliff, E. P., Gutierrez, A., & Davis, R. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600120-jlr200 · Cited by 49
A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
Shih, D. M., Kast-Woelbern, H. R., Wong, J., Xia, Y.-R., Edwards, P. A., & Lusis, A. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500378-jlr200 · Cited by 48
Studies on cholesterol metabolism in the diabetic rat
Nervi, F. O., González, A., & Valdivieso, V. D. (1974) · Metabolism · doi:10.1016/0026-0495(74)90077-8 · Cited by 47
Anisfeld, A. M., Kast-Woelbern, H. R., Lee, H. C., Zhang, Y., Lee, F. Y., & Edwards, P. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400292-jlr200 · Cited by 47
Cui, J., Heard, T. S., Yu, J., Lo, J., Huang, L., Li, Y., Schaeffer, J. M., & Wright, S. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200824200 · Cited by 46
Effect of Dietary Fat, Starch and Cellulose on Fecal Bile Acids in Mice
Bianchini, F., Caderni, G., Dolara, P., Fantetti, L., & Kriebel, D. (1989) · Journal of Nutrition · doi:10.1093/jn/119.11.1617 · Cited by 46
Ueda, J., Chijiiwa, K., Nakano, K., Zhao, G., & Tanaka, M. (2002) · Surgery · doi:10.1067/msy.2002.123008 · Cited by 45
Campana, G., Pasini, P., Roda, A., & Spampinato, S. M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.019 · Cited by 44
Identification of DRIP205 as a Coactivator for the Farnesoid X Receptor
Pineda‐Torra, I., Freedman, L. P., & Garabedian, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405126200 · Cited by 44
Cited by
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Metadata
- Authors
- Modica, S., Gadaleta, R. M., & Moschetta, A.
- Venue
- Nuclear Receptor Signaling
- Publisher
- SAGE Publications
- Published
- 2010-01
- Volume
- 8
- Issue
- 1
- Pages
- e005-e005
- ISSN
- 1550-7629 (ISSN-L)
- OpenAlex
- W1677336966
- Cited by
- 295
- References
- 208
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.